Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945620 | 0.80 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL787268 | 0.79 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL28133084 | 0.78 | — | — | |
| Bromide SCHEMBL11042423 | 0.77 | MEN1 (0.31) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7975590 | 0.77 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL8945835 | 0.76 | — | — | |
| SCHEMBL321521 | 0.73 | — | — | |
| SCHEMBL1137481 | 0.73 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL5267872 | 0.72 | — | — | |
| SCHEMBL23475212 | 0.71 | MEN1 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8268015-B2 | Method for decolorizing keratin-containing fibers | HENKEL AG & CO. KGAA (DE) | 2012-09-18 | — | — | US | disclosed |
| US-20120114831-A1 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2012-05-10 | — | — | US | disclosed |
| US-20110247644-A1 | Method for Decolorizing Keratin-Containing Fibers | HENKEL AG & CO. KGAA (DE) | 2011-10-13 | — | — | US | disclosed |
| US-8021686-B2 | Lipid-encapsulated polyanionic nucleic acid | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-09-20 | — | — | US | disclosed |
| EP-2113247-A2 | High efficiency encapsulation of nucleic acids in lipid vesicles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2009-11-04 | — | — | EP | disclosed |
| EP-1027033-B1 | HIGH EFFICIENCY ENCAPSULATION OF NUCLEIC ACIDS IN LIPID VESICLES | UNIV BRITISH COLUMBIA (CA) | 2009-07-22 | — | — | EP | disclosed |
| US-20080200417-A1 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2008-08-21 | — | — | US | disclosed |
| US-20080152604-A1 | SKIN-LIGHTENING COMPOSITIONS WITH AN IMPROVED ACTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-06-26 | — | — | US | disclosed |
| US-7341738-B2 | Lipid-encapsulated polyanionic nucleic acid | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2008-03-11 | — | — | US | disclosed |
| US-20050255153-A1 | Mixture of deprotonatable lipid, such as polyoxyethylene glycol or polyamide lipid with buffered aqueous solution of charged drug | INEX PHARMACEUTICALS CORP. (CA) | 2005-11-17 | — | — | US | disclosed |
| US-6858225-B2 | Lipid-encapsulated polyanionic nucleic acid | INEX PHARMACEUTICALS CORPORATION (CA) | 2005-02-22 | — | — | US | disclosed |
| US-20050008689-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | INEX PHARMACEUTICALS CORPORATION | 2005-01-13 | — | — | US | disclosed |
| US-20030129221-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | SEMPLE SEAN C (CA) | 2003-07-10 | — | — | US | disclosed |
| US-20020147121-A1 | Methods of enhancing cleaning compositions by combining alk(en)yl oligoglycosided and hydroxycarboxylic acid partial esters | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2002-10-10 | — | — | US | disclosed |
| US-6287591-B1 | STABLE FOR THERAPUTIC USE, HIV, CYTOMEGALO VIRUS, ANTIINFLAMMATORY, ANTITUMOR | INEX PHARMACEUTICALS CORP. (CA) | 2001-09-11 | — | — | US | disclosed |
| EP-1027033-A2 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | Inex Pharmaceuticals Corp. (CA) | 2000-08-16 | — | — | EP | disclosed |
| WO-1998051278-A2 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | INEX PHARMACEUTICALS CORPORATION (CA) | 1998-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008689-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | PHOSPHO1, LIPA, CHMP4B | MEN1 2561/4885KMT2A 971/4885 |
| US-20110247644-A1 | Method for Decolorizing Keratin-Containing Fibers | KRT18, PLOD3, DSG1 | MEN1 4660/4885KMT2A 228/4885 |
| US-20080200417-A1 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | PHOSPHO1, LIPA, CHMP4B | MEN1 2561/4885KMT2A 971/4885 |
| US-20050255153-A1 | Mixture of deprotonatable lipid, such as polyoxyethylene glycol or polyamide lipid with buffered aqueous solution of charged drug | PHOSPHO1, LIPA, CHMP4B | MEN1 2151/4885KMT2A 580/4885 |
| US-20030129221-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | PHOSPHO1, LIPA, CHMP4B | MEN1 2561/4885KMT2A 971/4885 |
| US-20080152604-A1 | SKIN-LIGHTENING COMPOSITIONS WITH AN IMPROVED ACTION | ALAD, TYR, CYP24A1 | MEN1 1792/4885KMT2A 4039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.